🧬 ICD-10 CM I69.092 — Facial Weakness Following Nontraumatic Subarachnoid Hemorrhage
Billable Code Confirmed
ICD-10 CM I69.092 is a fully billable, 7-character ICD-10-CM code valid for FY2026, meeting the highest level of specificity within the I69.09 subcategory. The code structure identifies: I69 (sequelae of cerebrovascular disease) → .0 (nontraumatic subarachnoid hemorrhage) → .09 (other sequelae) → .092 (facial weakness specifically). No additional characters are required, and this code is POA-reportable as a sequela condition.
Non-Billable Parent Codes
I69 (Sequelae of cerebrovascular disease) is a non-billable category-level code that requires additional characters specifying the type of cerebrovascular event and the nature of the sequela. I69.0 (Sequelae of nontraumatic subarachnoid hemorrhage) is non-billable — it identifies the event type but lacks the specificity to describe the deficit, making it unacceptable as a standalone reported code. I69.09 (Other sequelae of nontraumatic subarachnoid hemorrhage) is equally non-billable as a subcategory header — all three require extension to the 6th or 7th character for valid claim submission.
Clinical Context
ICD-10 CM I69.092 captures the specific residual neurological deficit of facial weakness — including facial droop, facial paresis, or central facial palsy — that persists following a nontraumatic subarachnoid hemorrhage (SAH). The mechanism in SAH differs from intracerebral hemorrhage: facial weakness post-SAH may result from direct cranial nerve VII compression by cisternal blood, vasospasm affecting facial nerve arterial supply, or cortical/subcortical ischemic injury from SAH-related vasospasm. This code is clinically and etiologically distinct from I69.192 (facial weakness following nontraumatic ICH), and documentation must explicitly link the facial deficit to the prior SAH event.
Code Classification
ICD-10 CM I69.092 is an ICD-10-CM diagnosis code — it is NOT a procedure code and carries no CPT or ICD-10-PCS equivalent. It classifies a sequela (late effect) of disease, meaning the acute subarachnoid hemorrhage phase has resolved and this code represents the residual neurological deficit. It is never appropriate to code I69.092 simultaneously with an active acute SAH code (I60.-) for the same hemorrhagic event.
🔍 Code Description
ICD-10 CM I69.092 identifies facial weakness as a sequela of a prior nontraumatic subarachnoid hemorrhage (SAH). Per ICD-10-CM Coding Guideline I.C.9.d, a sequela is a residual condition that persists after the acute phase has resolved, and there is no mandated time limit — this code can be used from the moment deficits are recognized or months to years post-event. Nontraumatic SAH most commonly results from rupture of a cerebral aneurysm (approximately 85% of cases) or, less frequently, arteriovenous malformation (AVM), and the cisternal blood from the rupture can cause direct compression of cranial nerve VII or trigger vasospasm of the arterial supply to the facial nerve nuclei in the brainstem, producing the facial weakness captured by I69.092. The facial weakness in SAH may present as either upper motor neuron (UMN) type — contralateral lower face involvement with forehead sparing, resulting from cortical/corticobulbar injury — or as lower motor neuron (LMN) type from direct cisternal blood compression of cranial nerve VII, making clinical documentation of mechanism particularly valuable for coding accuracy and CDI.
Facial weakness following SAH has significant functional implications including dysarthria, impaired oral feeding, and communication difficulty, all of which support medical necessity for skilled SLP and rehabilitation services and drive CPT code selection for profee billing. Coders should be aware that I69.092 can coexist with other sequela codes from the I69.0x subcategory when multiple residual deficits are present — for example, I69.091 (dysphagia following nontraumatic SAH) and I69.092 may both be reported when both deficits are documented and causally linked to the same SAH event, since ICD-10-CM guideline I.C.9.d explicitly permits concurrent I69 sequela codes when clinically supported. The distinction between SAH sequelae (I69.0x) and intracerebral hemorrhage sequelae (I69.1x) is etiologically important: SAH bleeds into the subarachnoid space surrounding the brain, while ICH bleeds directly into brain parenchyma, and each has its own code subcategory.
🌳 Code Tree / Hierarchy
I69 Sequelae of cerebrovascular disease ❌ Non-billable
│
├── I69.0 Sequelae of nontraumatic subarachnoid hemorrhage ❌ Non-billable
│ │
│ ├── I69.00 Unspecified sequelae of nontraumatic subarachnoid hemorrhage ✅ Billable
│ ├── I69.01x Cognitive deficits following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ ├── I69.02x Speech and language deficits following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ ├── I69.03x Monoplegia of upper limb following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ ├── I69.04x Monoplegia of lower limb following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ ├── I69.05x Hemiplegia and hemiparesis following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ ├── I69.06x Other paralytic syndrome following nontraumatic subarachnoid hemorrhage ✅ Billable (various 7th chars)
│ │
│ ├── I69.09 Other sequelae of nontraumatic subarachnoid hemorrhage ❌ Non-billable
│ │ │
│ │ ├── I69.090 Apraxia following nontraumatic subarachnoid hemorrhage ✅ Billable
│ │ ├── I69.091 Dysphagia following nontraumatic subarachnoid hemorrhage ✅ Billable
│ │ ├── I69.092 Facial weakness following nontraumatic subarachnoid hemorrhage ◀ THIS CODE ✅ Billable
│ │ ├── I69.093 Ataxia following nontraumatic subarachnoid hemorrhage ✅ Billable
│ │ └── I69.098 Other sequelae following nontraumatic subarachnoid hemorrhage ✅ Billable
│ │
├── I69.1 Sequelae of nontraumatic intracerebral hemorrhage ❌ Non-billable
│ └── I69.192 Facial weakness following nontraumatic intracerebral hemorrhage ✅ Billable
│
└── I69.2 Sequelae of other nontraumatic intracranial hemorrhage ❌ Non-billable
Why I69.092 Over I69.098?
ICD-10 CM I69.098 is the catch-all “other specified sequelae” code for nontraumatic SAH and should only be used when no specific sequela code exists for the documented deficit. Facial weakness has its own dedicated code at I69.092, making I69.098 a specificity failure for this diagnosis — payers and auditors expect the most precise code supported by documentation, and use of I69.098 when I69.092 is available is a common coding error that can trigger claim review.
Tip
When a patient with prior SAH presents with facial weakness, query the physician to confirm: (1) the explicit causal link to the prior subarachnoid hemorrhage, (2) the mechanism of the facial palsy if documented (UMN vs LMN type — supports clinical specificity even though I69.092 does not subdivide by mechanism), and (3) whether other deficits are also present (dysphagia, ataxia, apraxia, hemiplegia) that warrant additional I69.0x codes and may carry HCC value.
✅ Includes
- Facial droop following nontraumatic subarachnoid hemorrhage — downward displacement or asymmetry of facial musculature as a residual deficit from either cortical injury or direct cranial nerve VII compression by cisternal blood from the prior SAH.
- Central facial palsy following nontraumatic SAH — upper motor neuron pattern weakness affecting the contralateral lower two-thirds of the face, resulting from corticobulbar tract disruption due to SAH-related ischemia or hemorrhagic injury.
- Post-SAH facial paresis — partial loss of voluntary facial movement persisting as a residual deficit after the acute subarachnoid hemorrhage event has resolved.
❌ Excludes
Excludes 1
Z86.73 — Personal history of cerebral infarction without residual deficit (PRIND/RIND): This Excludes 1 note at the I69.0 category level prohibits coding Z86.73 simultaneously with I69.092, because Z86.73 is used only when NO residual neurological deficits are present from a prior cerebrovascular event. The presence of an ongoing facial weakness sequela means the patient does not qualify for Z86.73 — these are mutually exclusive by definition, and billing both together is a non-compliant code pairing that misrepresents the patient’s neurological status. S06.- — Sequelae of traumatic intracranial injury: This Excludes 1 note prohibits I69.092 when the SAH was caused by trauma; traumatic subarachnoid hemorrhage sequelae require codes from the S06 injury chapter with the appropriate sequela 7th character (S), and these categories cannot be coded together for the same event.
Danger
The most common Excludes 1 error with I69.092 is assigning Z86.73 alongside it when a coder pulls the SAH history from the medical record and adds a “history” code without recognizing that the active facial weakness makes Z86.73 incorrect. This error contradicts the patient’s clinical picture — if sequelae exist, Z86.73 is off the table entirely.
Excludes 2
ICD-10 CM I69.192 — Facial weakness following nontraumatic intracerebral hemorrhage: This is an Excludes 2 scenario, meaning if a patient has a documented history of BOTH a prior nontraumatic SAH AND a separate prior nontraumatic ICH, each causing its own distinct facial weakness residual, both I69.092 and I69.192 could be reported simultaneously when documentation supports two discrete causative hemorrhagic events. In practice, this dual scenario requires unambiguous physician documentation specifying which facial weakness deficit is attributed to the SAH versus the ICH — a prime CDI query opportunity when both hemorrhagic events are in the history and facial weakness is documented without etiology specificity.
📋 Clinical Overview
SAH vs. ICH vs. Peripheral Facial Weakness: Code Selection Drivers
Facial weakness following nontraumatic SAH requires precise etiologic distinction both clinically and from a coding perspective. SAH bleeds into the subarachnoid space and can produce facial weakness through two distinct mechanisms: (1) UMN pathway disruption from ischemia secondary to cerebral vasospasm affecting the motor cortex or corticobulbar tracts, or (2) direct LMN compression of cranial nerve VII by cisternal blood accumulation near the brainstem, an important distinction not captured by the code itself but critical for physician documentation and CDI query language. Selecting I69.092 over I69.192 (ICH) or G51.0 (Bell’s palsy) hinges entirely on the documented etiology documented in the medical record, which is why provider linkage language such as “facial weakness as sequela of prior nontraumatic subarachnoid hemorrhage” is non-negotiable for compliant coding.
| Feature | I69.092 | I69.192 | G51.0 |
|---|---|---|---|
| Etiology | Sequela of nontraumatic subarachnoid hemorrhage | Sequela of nontraumatic intracerebral hemorrhage | Idiopathic peripheral facial nerve palsy (Bell’s palsy) |
| Hemorrhage Location | Subarachnoid space (surrounding brain/cisterns) | Brain parenchyma (within brain tissue) | No hemorrhage — idiopathic nerve inflammation |
| Mechanism of Facial Weakness | UMN (vasospasm/cortical ischemia) or LMN (cranial nerve VII cisternal compression) | UMN (corticobulbar tract disruption from parenchymal lesion) | LMN (peripheral facial nerve demyelination/inflammation) |
| Forehead Sparing | Possible (UMN type) or absent (LMN type) | Yes — typically spared (UMN pattern) | No — entire ipsilateral face affected including forehead |
| HCC Impact (V28) | No independent HCC value | No independent HCC value | No HCC value |
| DRG Driver | DRG 056/057 as PDX (MDC 01) | DRG 056/057 as PDX (MDC 01) | MDC 01 depending on PDX context |
Important
CDI trigger: Any patient with a documented history of nontraumatic SAH presenting with facial weakness, asymmetry, or droop should prompt a physician query to confirm: (1) whether the facial weakness is a sequela of the prior SAH, (2) whether it was present at admission (POA status), and (3) whether additional residual deficits from the SAH exist that warrant additional I69.0x codes — particularly hemiplegia codes that carry HCC 103.
Manifestations & Symptom Burden
- Dysarthria (R47.81): Facial muscle weakness contributes to slurred or imprecise speech articulation; may be separately coded when documented as distinct from the facial weakness itself, supporting SLP referral and CPT 92507 billing.
- Dysphagia (I69.091): Can coexist as a separate sequela code when oropharyngeal muscle impairment from the same SAH event is documented; both I69.091 and I69.092 may be reported simultaneously per ICD-10-CM sequela coding guidelines.
- Oral feeding difficulty (R63.3): Secondary functional impact of facial weakness affecting lip seal and oral bolus management; supports skilled SLP care medical necessity documentation.
- Headache (G44.309): Chronic post-SAH headache is a well-documented sequela distinct from the facial weakness; code separately when documented as an ongoing residual condition to fully represent the patient’s post-SAH burden.
- Psychosocial sequelae: Post-SAH anxiety, depression, and PTSD are common and should be captured with appropriate F-chapter codes when documented by the treating provider, as these directly affect care planning and rehabilitation intensity.
Tip
Manifestation coding pearl: I69.092 is a sequela code functioning as a standalone diagnosis — it does not use the etiology/manifestation coding convention. You do not need a separate “code first” instruction. The “use additional code” note at I69.091 applies specifically to dysphagia severity (R13.1x); I69.092 does not carry a parallel “use additional code” instruction for facial weakness severity grading, though documenting House-Brackmann grade in the record strengthens rehabilitation medical necessity.
💰 HCC Risk Adjustment
| Model | HCC Assignment | RAF Impact | Notes |
|---|---|---|---|
| CMS HCC V28 (MA) | None — not HCC-mapped | No independent RAF score | Isolated facial weakness does not trigger HCC |
| CMS HCC V24 (legacy) | None — not HCC-mapped | No independent RAF score | SAH hemiplegia sequelae (I69.05x) carry HCC 103 |
| CDPS | Not applicable to inpatient DRG | N/A | N/A |
ICD-10 CM I69.092 carries no independent RAF value under CMS HCC Model V28, meaning it will not boost a patient’s risk score or drive MA plan reimbursement on its own. Despite this, accurate documentation and coding of I69.092 remains important — it captures the full neurological burden of the post-SAH patient and supports medical necessity for ongoing rehabilitation. When the same SAH event produced hemiplegia or hemiparesis (I69.051-I69.054), those codes DO carry HCC 103 under V28 and must be captured alongside I69.092 when clinically supported. For profee coders performing inpatient documentation reviews, the absence of HCC value for I69.092 should not lead to underreporting — complete sequela capture is a compliance requirement regardless of RAF impact.
🏥 MS-DRG Assignment
| Sequencing Role | MCC Present | CC Present | Assigned DRG | MDC |
|---|---|---|---|---|
| Principal Diagnosis | Yes | N/A | DRG 056 — Degenerative Nervous System Disorders with MCC | MDC 01 |
| Principal Diagnosis | No | N/A | DRG 057 — Degenerative Nervous System Disorders without MCC | MDC 01 |
| Secondary Diagnosis | Varies | Varies | Driven by PDX; I69.092 CC/MCC status per FY2026 v43.0 grouper | MDC 01 |
When I69.092 is the principal diagnosis (e.g., patient admitted for inpatient rehabilitation evaluation of post-SAH facial weakness and associated neurological deficits), it groups to MDC 01 under DRG 056 with MCC or DRG 057 without MCC. The DRG 056/057 pair covers degenerative nervous system disorders and consistently captures sequelae of cerebrovascular events presenting as the primary admission driver. CC/MCC designations of secondary diagnoses are the key weight driver after DRG assignment — always verify the current FY2026 v43.0 grouper for updated CC/MCC status, as CMS revises these annually. For inpatient profee coding, per UHDDS guidelines, the principal diagnosis is the condition chiefly responsible for occasioning the admission after study — if post-SAH facial weakness rehabilitation is the primary driver, I69.092 earns PDX status.
🔗 Related ICD-10-CM Codes
Other Sequelae of Nontraumatic SAH (I69.09x Family)
- I69.090 — Apraxia following nontraumatic subarachnoid hemorrhage
- I69.091 — Dysphagia following nontraumatic subarachnoid hemorrhage
- I69.093 — Ataxia following nontraumatic subarachnoid hemorrhage
- I69.098 — Other sequelae following nontraumatic subarachnoid hemorrhage (catch-all; use only when no specific code exists)
Facial Weakness Sequelae — Cross-Etiology Comparison Codes
- I69.192 — Facial weakness following nontraumatic intracerebral hemorrhage
- I69.292 — Facial weakness following other nontraumatic intracranial hemorrhage
- I69.392 — Facial weakness following cerebral infarction
- I69.892 — Facial weakness following other cerebrovascular disease
- I69.992 — Facial weakness following unspecified cerebrovascular disease
- G51.0 — Bell’s palsy (peripheral; active idiopathic facial palsy — not a sequela code)
- Z86.73 — Personal history of cerebral infarction without residual deficit (use ONLY when NO sequelae are present)
🛠️ Commonly Associated CPT Codes
NCCI Bundling Considerations
When billing rehabilitation CPT codes for post-SAH facial weakness, ensure that speech therapy codes (92507) and physical/occupational therapy codes (97110, 97530) are not billed together by the same provider discipline on the same day without appropriate NCCI-bypassing modifiers (XP for separate practitioners). NCCI edits bundle many therapeutic procedure codes when billed by the same discipline in the same session — always reference the current NCCI table before billing multiple rehab codes on the same DOS. Inpatient facility coders should note that therapy CPT codes are captured under the DRG for the facility and are not separately reported; the profee side bills E/M or rehabilitation medicine codes independently.
92507 — Treatment of speech, language, voice, communication, and/or auditory processing (individual): Billed by SLPs for post-SAH facial weakness contributing to dysarthria or communication deficits; CMS LCD A52866 specifically lists I69.092 as a covered diagnosis for speech-language pathology services. Requires a physician order and documentation of skilled care necessity with measurable functional goals.
97110 — Therapeutic exercises (15-minute timed units): Billed by PT or OT for neuromuscular strengthening targeting facial musculature or associated extremity deficits; documentation must demonstrate skilled intervention with measurable progress toward functional goals. When billed by a different discipline than SLP on the same DOS, modifier XP may be required to bypass NCCI edits.
97112 — Neuromuscular reeducation: Particularly appropriate for post-SAH facial weakness as it specifically targets reeducation of movement, balance, and kinesthetic sense in neurologically impaired patients; supports motor relearning approaches for both UMN and LMN type facial palsy patterns resulting from the prior SAH.
97530 — Therapeutic activities: Applies when facial weakness is addressed in the context of ADL retraining such as eating, oral hygiene, and communication; billed in 15-minute timed units with GP modifier for PT services under Medicare. Strong medical necessity documentation linking post-SAH facial weakness to the functional activity limitation is required for audit defensibility.
99233 — Subsequent hospital care (high medical decision-making complexity): The attending physician’s daily profee E/M code during an inpatient stay where post-SAH neurological deficits including facial weakness require ongoing management and rehabilitation coordination; MDM complexity is supported by the neurological sequela burden and multi-disciplinary team coordination.
🔬 ICD-10-PCS Crosswalk
ICD-10-PCS procedure codes represent the procedures performed to address the condition — there is no PCS code that maps to the diagnosis of facial weakness itself. The following PCS codes represent inpatient procedures that may be documented during a stay where I69.092 is a relevant diagnosis:
F07Z6ZZ — Motor Treatment of Facial Muscles using Therapeutic Exercise (Physical Rehabilitation and Diagnostic Audiology section): Captures inpatient physical rehabilitation targeting facial motor function; applicable when the rehabilitation team performs structured therapeutic exercise directed at facial musculature as part of the post-SAH recovery plan.
F09Z0ZZ — Assessment of Facial Muscles Motor Function (Physical Rehabilitation and Diagnostic Audiology section): Used when a formal motor function assessment of facial musculature is performed as part of the inpatient rehabilitation evaluation, establishing baseline deficit severity prior to developing a structured rehabilitation plan.
F06ZUZZ — Speech Treatment using Augmentative/Alternative Communication (Rehabilitation section): Applicable when post-SAH facial weakness is severe enough to impair verbal communication and augmentative communication strategies are initiated during the inpatient stay as part of the SLP treatment plan.
💊 Coding Scenarios and Examples
Scenario 1 — Inpatient Rehab Admission Post-SAH Ms. R, a 52-year-old female, is admitted to inpatient rehabilitation 4 weeks after a nontraumatic SAH from a ruptured anterior communicating artery aneurysm. The attending physiatrist documents residual left-sided facial droop, mild dysphagia, and balance instability, all linked as sequelae of the prior SAH. She requires skilled PT, OT, and SLP services for functional recovery.
- Correct Coding: I69.092 (facial weakness), I69.091 (dysphagia following nontraumatic SAH), I69.093 (ataxia following nontraumatic SAH)
- Sequencing: I69.092 or I69.093 as PDX based on which deficit drove the admission (physiatrist documentation determines this); all three as concurrent sequela codes
- CDI Note: Physiatrist must explicitly document each deficit as a sequela of the prior SAH — “residual left facial droop due to prior nontraumatic SAH from ACoA aneurysm rupture” — vague documentation like “h/o SAH, facial droop” without causal linkage language does not support I69.092.
Scenario 2 — Outpatient Neurology Follow-Up (Profee) Mr. V, a 61-year-old male, presents to neurology clinic 3 months after a nontraumatic SAH from a ruptured MCA aneurysm. He reports persistent right-sided facial drooping and difficulty with speech clarity. No hemiplegia is present. The neurologist documents “right facial weakness and dysarthria, residual sequelae of prior nontraumatic subarachnoid hemorrhage.”
- Correct Coding: I69.092 (facial weakness as first-listed), R47.81 (dysarthria, separately documented)
- Sequencing: I69.092 as first-listed diagnosis; R47.81 as additional if distinct and documented
- CDI Note: Verify neurologist explicitly linked each deficit to the SAH — “dysarthria and facial weakness, history of SAH” without the causal linkage phrase may not be sufficient without a query to the provider.
Scenario 3 — Acute Inpatient Admission with Post-SAH Comorbidity Mrs. P is admitted acutely for aspiration pneumonia (J69.0). She has a prior history of nontraumatic SAH with residual facial weakness (I69.092) and dysphagia (I69.091), both documented as active comorbidities contributing to the aspiration event. Physician documents facial weakness and dysphagia as ongoing SAH sequelae complicating her current admission.
- Correct Coding: J69.0 (PDX — aspiration pneumonia), I69.092 (facial weakness — secondary), I69.091 (dysphagia — secondary)
- Sequencing: J69.0 as PDX since the pneumonia prompted the admission; SAH sequela codes as secondary diagnoses affecting care; sequela codes may add CC/MCC weight — verify per grouper
- CDI Note: This is a powerful CDI scenario — the documented post-SAH facial weakness and dysphagia as the mechanism of aspiration creates a tight, documented causal chain supporting J69.0 as the PDX and both sequela codes as clinically relevant secondary diagnoses.
⚠️ Coding Pitfalls and Tips
- Never code I69.092 with an active SAH code simultaneously for the same hemorrhagic event. Codes from I60.- (nontraumatic SAH) represent the acute phase; once resolved with persistent facial weakness, transition to I69.092. These two codes are mutually exclusive for the same event — coding both is a sequencing error that will trigger a claim edit and represent a misunderstanding of the sequela coding convention.
- Do not default to I69.098 when I69.092 is available. I69.098 is the “other specified” catch-all and is inappropriate when facial weakness is the documented deficit — I69.092 exists precisely for this scenario. Using I69.098 for facial weakness is a specificity failure that can result in a down-coded claim, audit finding, or medical necessity denial for associated rehabilitation services.
- Z86.73 and I69.092 cannot coexist. Z86.73 requires that NO residual deficit be present; if the patient has facial weakness, Z86.73 is excluded by the Excludes 1 note at I69.0. This error most commonly occurs when a coder sees “history of SAH” in the problem list and reflexively adds Z86.73 without checking for active sequela codes already assigned.
- The causal documentation linkage is non-negotiable per Guideline I.C.9.d. “Facial weakness” alone in a patient with SAH history does not authorize I69.092 — the provider must document the link. Implied causality is insufficient; query when documentation states “h/o SAH” and “facial weakness” without connecting them, especially in inpatient profee where audit exposure is high.
- SAH facial weakness can be UMN or LMN in pattern. Unlike ICH, which almost exclusively produces UMN-type facial palsy, SAH can produce either UMN or LMN facial weakness depending on whether the injury is cortical/vascular or from direct cranial nerve VII compression by cisternal blood. Neither subtype has its own code in I69.092, but clinical documentation of the pattern is valuable for rehabilitation planning and CDI completeness.
NOTE
- Multiple I69.09x codes may and should be coded simultaneously. If the patient has facial weakness, dysphagia, and ataxia all from the same SAH event, assign I69.092 + I69.091 + I69.093 concurrently — this is accurate, compliant, and maximizes representation of the patient’s full neurological burden, supporting both DRG complexity and rehabilitation medical necessity.